Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
54 /100
HIGH RISK
Score updated Oct 13, 2026

ZYBT — Zhengye Biotechnology Holding Limited Dilution Risk Tracker

Track ZYBT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ZYBT — Get alerts when the score changes →

As of October 13, 2026, Zhengye Biotechnology Holding Limited (ZYBT) has a DilutionWatch DilutionScore of 54/100, rated HIGH dilution risk. Zhengye Biotechnology Holding Limited has a market capitalization of $76.30M, 47.39M shares outstanding, 8 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
65
📊 Float Risk
80
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 37%
🔄 Reverse Split model est. 65%
• 50-day avg $0.93 below $1 exchange minimum
• 8 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (8mo)
🔔 Track ZYBT — Get forecast alerts →

Market Data

Market Cap$76.30M
Shares Outstanding47.39M
Float6.26M
Cash$2.77M
Debt$758.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore54/100DilutionWatch score record
Shares Outstanding47.39MVerified float table or market cache
Public Float6.26MVerified float table or market cache
Market Cap$76.30MMarket data cache
Cash Runway8.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 0.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 46.0% shares (2026Q1 vs prior)
8 institutional holders · 124.7K shares
#1 XTX Topco Ltd 44.1K shares
#2 WINTON GROUP Ltd 33.4K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 29.1K shares
+ 5 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest115.1K
Days to Cover5.6
% of Float1.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news available for this ticker.

DilutionScore History — Last 90 Days

ZYBT's DilutionScore is currently 54/100 (High risk), with 1 score change tracked over 89 days. The score improved from 34/100 (Medium risk).

Period Score Risk Level Duration
Oct 04 – Oct 13, 202654/100HIGH10 days
Jul 16 – Oct 03, 202634/100MEDIUM79 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track ZYBT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ZYBT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ZYBT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ZYBT
ZYBT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.